Grethe Dalsgaard

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Phillips-Medisize A/S designs, develops, and manufactures injection, inhalation, and connectivity devices. It co-markets intelligent patient compliance device solutions that enable patients to manage their drug treatment regimes. The firm offers pressurized metered dose inhalers, such as Asmair for asthma and chronic obstructive pulmonary diseases; and Insulair, for use with liquid drug formulations for pulmonary drug delivery in patients with diabetes; and tablet reminders. The company's injection technology accelerators are focuses on modules and concept solutions for: disposable and reusable concepts, mechanical and electronic motor systems, dosing controls, needle protection systems, low and high volume concepts, data collection and memory systems, and wireless data transfer systems. Medicom Innovation Partner was founded in 1989 and is headquartered in Struer, Denmark.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Norgine Pharmaceuticals Ltd. develops, manufactures and markets pharmaceutical products. Its products include destolit, klean-prep, movicol, movicol chocolate, movicol paediatric chocolate, normacol, setofilm 4mg/8mg, targxan 550mg, xerotin, xifaxanta 200mg and endocuff vision. The company was founded in 1906 and is headquartered in Middlesex, the United Kingdom.

NYX, Inc. provides interior, under-hood, and technology solution to the automotive industry. It offers plastics processing, engineered plastics, rubber extrusion, steel stamping, and assembly. The firm has operations in Michigan, Tennessee, and Mexico. The company is headquartered in Livonia, MI.

KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark.

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Norgine Europe BV provides pharmaceutical products. It offers products for acute and chronic illnesses, including gastroenterology, hepatology, incontinence and pain management. The company was founded in 1906 and is headquartered in Amsterdam, the Netherlands.

Founded in 1906, Norgine is a specialty pharmaceutical company with an extensive pan-European presence. Throughout its long history, they have sought to develop and market high quality, innovative products for the benefit of both patients and physicians. They are committed to developing products not only to treat life-threatening conditions but, importantly, to improve the quality of life for patients with a range of acute and chronic illnesses. They have a long standing tradition of building relationships, based on the highest standards, with patients, physicians, employees, partners and other key stakeholders. In the last fifteen years, they have focused on expanding its pan-European infrastructure, and have moved to strengthen the Research & Development base of the company. In addition to developing, manufacturing and marketing its own pharmaceutical products, Norgine is an ideal partner for companies seeking assistance in the development and launch of innovative pharmaceutical products across Europe. They value its development partnerships as, together with its own in-house product development; they support its growth ambitions and will help to facilitate its continued business expansion. They have the resources to bring products to market on a pan-European or single country basis, combining sales and marketing expertise together with all development, clinical research, and product registration or manufacturing resources that its partners require. In the years ahead Norgine will continue to implement this successful strategy, building on its established infrastructure, strengthening its pan-European presence and collaborating with like-minded companies and organizations.

Norgine Ltd. provides pharmaceutical services. The company is headquartered in South Wales, the United Kingdom.

Norgine Pharma manufactures pharmaceutical product. It offers medicines, vaccines, tablets and injection. The company is headquartered in Dreux, France.

Norgine BV engages in development and manufacture of pharmaceutical products. It is specialized in gastroenterology, hepatology, cancer, and supportive care. The firms brands include Depoint, Elantan, Emselex, Estraderm, Givalex, Isoket, Nortussine, Provames, Sintrom, Speciafoldine, Surgestone, and Tredemine. The company was founded by Victor Stein in 1906 and is headquartered in Amsterdam, the Netherlands.

iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.

SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland.

Arc Medical Design Ltd. manufactures and supplies medical, dental instruments. Its products are ENDOCUFF and Wide-Eye Polyptrap. The company was founded on October 7, 2008 and is headquartered in Leeds, the Unite Kingdom.

Pistoia Alliance, Inc. is an American life science company that operates in research and development. The private company is based in Boston.

Grit42 A/S develops software that renders insights, visualization, analysis, and data management for pre-clinical drug discovery. The private company is based in Copenhagen, Denmark. Claus S. Kallesoe has been the CEO of the Danish company since 2014.

Goldman Sachs Bank LLC (Broker) (GS Bank-Broker) is the broker-dealer division of Raiffeisenbank AO, which is owned by Raiffeisen Bank International AG (VIE: RBI; OTCMKTS: RAIFY) in Austria. The firm was founded in 1998 and is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS) in the US. Headquartered in Moscow, GS Bank-Broker provides market insight, risk management and execution services to institutional clients including Asset Managers, Hedge Funds, Banks and Brokerages, Pensions, Endowments and Foundations, Corporations, and Governments.